These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 22738085)

  • 1. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.
    Perner A; Haase N; Guttormsen AB; Tenhunen J; Klemenzson G; Åneman A; Madsen KR; Møller MH; Elkjær JM; Poulsen LM; Bendtsen A; Winding R; Steensen M; Berezowicz P; Søe-Jensen P; Bestle M; Strand K; Wiis J; White JO; Thornberg KJ; Quist L; Nielsen J; Andersen LH; Holst LB; Thormar K; Kjældgaard AL; Fabritius ML; Mondrup F; Pott FC; Møller TP; Winkel P; Wetterslev J; ;
    N Engl J Med; 2012 Jul; 367(2):124-34. PubMed ID: 22738085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyethyl starch in severe sepsis: end of starch era?
    Estrada CA; Murugan R
    Crit Care; 2013 Mar; 17(2):310. PubMed ID: 23509901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyethyl starch in sepsis.
    Haase NR
    Dan Med J; 2014 Jan; 61(1):B4764. PubMed ID: 24393593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate.
    Perner A; Haase N; Winkel P; Guttormsen AB; Tenhunen J; Klemenzson G; Müller RG; Aneman A; Wetterslev J
    Intensive Care Med; 2014 Jul; 40(7):927-34. PubMed ID: 24807084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial.
    Perner A; Haase N; Wetterslev J; Aneman A; Tenhunen J; Guttormsen AB; Klemenzson G; Pott F; Bødker KD; Bådstøløkken PM; Bendtsen A; Søe-Jensen P; Tousi H; Bestle M; Pawlowicz M; Winding R; Bülow HH; Kancir C; Steensen M; Nielsen J; Fogh B; Madsen KR; Larsen NH; Carlsson M; Wiis J; Petersen JA; Iversen S; Schøidt O; Leivdal S; Berezowicz P; Pettilä V; Ruokonen E; Klepstad P; Karlsson S; Kaukonen M; Rutanen J; Karason S; Kjældgaard AL; Holst LB; Wernerman J;
    Trials; 2011 Jan; 12():24. PubMed ID: 21269526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double-blind clinical trial.
    Béchir M; Puhan MA; Fasshauer M; Schuepbach RA; Stocker R; Neff TA
    Crit Care; 2013 Dec; 17(6):R299. PubMed ID: 24365167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis.
    Anthon CT; Müller RB; Haase N; Hjortrup PB; Møller K; Lange T; Wetterslev J; Perner A
    Acta Anaesthesiol Scand; 2017 Sep; 61(8):904-913. PubMed ID: 28653377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis.
    Müller RB; Haase N; Lange T; Wetterslev J; Perner A
    Acta Anaesthesiol Scand; 2015 Mar; 59(3):329-36. PubMed ID: 25524831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial.
    Haase N; Wetterslev J; Winkel P; Perner A
    Intensive Care Med; 2013 Dec; 39(12):2126-34. PubMed ID: 24081433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
    Brunkhorst FM; Engel C; Bloos F; Meier-Hellmann A; Ragaller M; Weiler N; Moerer O; Gruendling M; Oppert M; Grond S; Olthoff D; Jaschinski U; John S; Rossaint R; Welte T; Schaefer M; Kern P; Kuhnt E; Kiehntopf M; Hartog C; Natanson C; Loeffler M; Reinhart K;
    N Engl J Med; 2008 Jan; 358(2):125-39. PubMed ID: 18184958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
    Bagshaw SM; Chawla LS
    Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystalloids vs. colloids: KO at the twelfth round?
    Phillips DP; Kaynar AM; Kellum JA; Gomez H
    Crit Care; 2013 May; 17(3):319. PubMed ID: 23731998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyethyl starch or saline for fluid resuscitation in intensive care.
    Myburgh JA; Finfer S; Bellomo R; Billot L; Cass A; Gattas D; Glass P; Lipman J; Liu B; McArthur C; McGuinness S; Rajbhandari D; Taylor CB; Webb SA; ;
    N Engl J Med; 2012 Nov; 367(20):1901-11. PubMed ID: 23075127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial.
    Wittbrodt P; Haase N; Butowska D; Winding R; Poulsen JB; Perner A; ;
    Crit Care; 2013 Feb; 17(2):R58. PubMed ID: 23531324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature.
    Serpa Neto A; Veelo DP; Peireira VG; de Assunção MS; Manetta JA; Espósito DC; Schultz MJ
    J Crit Care; 2014 Feb; 29(1):185.e1-7. PubMed ID: 24262273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three fluid solutions for resuscitation in dengue shock syndrome.
    Wills BA; Nguyen MD; Ha TL; Dong TH; Tran TN; Le TT; Tran VD; Nguyen TH; Nguyen VC; Stepniewska K; White NJ; Farrar JJ
    N Engl J Med; 2005 Sep; 353(9):877-89. PubMed ID: 16135832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Hospital and Patient Characteristics with Fluid Resuscitation Volumes in Patients with Severe Sepsis: Post Hoc Analyses of Data from a Multicentre Randomised Clinical Trial.
    Hjortrup PB; Haase N; Wetterslev J; Perner A
    PLoS One; 2016; 11(5):e0155767. PubMed ID: 27196104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetate Ringer's solution versus 0.9% saline for septic patients: study protocol for a multi-center parallel controlled trial.
    Liu F; Zhang J; Zhu Y; Su L; Li Y; He L; Yu L; Peng Z
    Trials; 2021 Jan; 22(1):89. PubMed ID: 33494795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial.
    Müller RG; Haase N; Wetterslev J; Perner A
    Intensive Care Med; 2013 Nov; 39(11):1963-71. PubMed ID: 24037226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboelastography in patients with severe sepsis: a prospective cohort study.
    Haase N; Ostrowski SR; Wetterslev J; Lange T; Møller MH; Tousi H; Steensen M; Pott F; Søe-Jensen P; Nielsen J; Hjortrup PB; Johansson PI; Perner A
    Intensive Care Med; 2015 Jan; 41(1):77-85. PubMed ID: 25413378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.